Study identifier:BY9010/M1-206
ClinicalTrials.gov identifier:NCT00163462
EudraCT identifier:N/A
CTIS identifier:N/A
Comparison of ciclesonide (80 mcg or 160 mcg once daily in the evening) and fluticasone propionate (100 mcg twice daily in the morning and evening) in pediatric asthma patients
asthma
Phase 3
No
Ciclesonide
All
750
Interventional
6 Years - 11 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Oct 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|